Codexis, Inc. (CDXS)Healthcare | Biotechnology | Redwood City, United States | NasdaqGS
2.43 USD
-0.19
(-7.252%) ⇩
(April 21, 2026, 1:41 p.m.
EDT)
Short-term: ★★☆☆☆ | Long-term: ☆☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 18, 2026, 11:44 p.m. EDT
CDXS is a fundamental trap with a balance sheet of effectively zero equity ($500k) amidst negative cash flow, capped by the looming Nasdaq rebalancing. Despite a bounce to $2.59, the unwinding of short interest suggests a crowded short, but the 2.09 beta and lack of profitability make it a high-risk bet. The long-dated call flow at $5.00 is pure speculation on a cure-all, not a financial reality, keeping the price toast of eventual liquidation or dilution. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.212665 |
| MSTL | 0.212936 |
| AutoARIMA | 0.221350 |
| AutoTheta | 0.225227 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 48% |
| H-stat | 4.93 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.189 |
| Excess Kurtosis | -0.61 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 144.883 |
| Revenue per Share | 0.808 |
| Market Cap | 220,812,528 |
| Forward P/E | -11.05 |
| Beta | 2.08 |
| Profit Margins | -62.47% |
| Website | https://www.codexis.com |
As of April 18, 2026, 11:44 p.m. EDT: Options flow shows extreme divergence in sentiment. Near-term (April 17), bears dominate with significant put open interest (OI) at strikes $0.5, $1.0, and $2.0, while call volume is negligible and open interest near zero. Long-dated calls (June) show a massive volume spike ($200 contracts) at the $5.0 strike, representing a highly leveraged long-term directional bet, but current market pricing and IV suggest this is a speculative flyer rather than broad accumulation. The Implied Volatility for near-term puts is elevated (~16.5), whereas long-dated calls have crushing IV (~1.0), indicating the market prices a low-near-term but psychologically significant rise-to-me $5 target further out.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.1748879 |
| Address1 | 200 Penobscot Drive |
| All Time High | 42.01 |
| All Time Low | 0.96 |
| Ask | 3.07 |
| Ask Size | 2 |
| Audit Risk | 6 |
| Average Daily Volume10 Day | 1,645,760 |
| Average Daily Volume3 Month | 2,408,685 |
| Average Volume | 2,408,685 |
| Average Volume10Days | 1,645,760 |
| Beta | 2.084 |
| Bid | 2.27 |
| Bid Size | 5 |
| Board Risk | 6 |
| Book Value | 0.558 |
| City | Redwood City |
| Compensation As Of Epoch Date | 1,735,603,200 |
| Compensation Risk | 10 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 2.43 |
| Current Ratio | 3.824 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 2.64 |
| Day Low | 2.39 |
| Debt To Equity | 144.883 |
| Display Name | Codexis |
| Earnings Call Timestamp End | 1,773,261,000 |
| Earnings Call Timestamp Start | 1,773,261,000 |
| Earnings Timestamp | 1,773,259,200 |
| Earnings Timestamp End | 1,778,702,400 |
| Earnings Timestamp Start | 1,778,702,400 |
| Ebitda | -33,084,000 |
| Ebitda Margins | -0.47002998 |
| Enterprise To Ebitda | -7.045 |
| Enterprise To Revenue | 3.311 |
| Enterprise Value | 233,076,688 |
| Eps Current Year | -0.31667 |
| Eps Forward | -0.22 |
| Eps Trailing Twelve Months | -0.5 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 1.5698 |
| Fifty Day Average Change | 0.86020005 |
| Fifty Day Average Change Percent | 0.5479679 |
| Fifty Two Week Change Percent | 17.488789 |
| Fifty Two Week High | 3.87 |
| Fifty Two Week High Change | -1.4399998 |
| Fifty Two Week High Change Percent | -0.372093 |
| Fifty Two Week Low | 0.96 |
| Fifty Two Week Low Change | 1.47 |
| Fifty Two Week Low Change Percent | 1.5312501 |
| Fifty Two Week Range | 0.96 - 3.87 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,271,943,000,000 |
| Float Shares | 72,948,096 |
| Forward Eps | -0.22 |
| Forward P E | -11.045455 |
| Free Cashflow | -5,074,125 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 146 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,775,001,600 |
| Gross Margins | 0.1242 |
| Gross Profits | 8,742,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.07571 |
| Held Percent Institutions | 0.74708 |
| Implied Shares Outstanding | 90,869,349 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Codexis, Inc. provides technology solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, enhance, and commercialize novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China. The company develops its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a license agreement with Aldevron LLC and Pfizer Inc. The company was incorporated in 2002 and is headquartered in Redwood City, California. |
| Long Name | Codexis, Inc. |
| Market | us_market |
| Market Cap | 220,812,528 |
| Market State | REGULAR |
| Max Age | 86,400 |
| Message Board Id | finmb_3160285 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -43,974,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 238,077,694 |
| Number Of Analyst Opinions | 6 |
| Open | 2.64 |
| Operating Cashflow | -19,376,000 |
| Operating Margins | 0.35888 |
| Overall Risk | 9 |
| Payout Ratio | 0.0 |
| Peg Ratio | 13.53 |
| Phone | 650 421 8100 |
| Previous Close | 2.62 |
| Price Eps Current Year | -7.6736035 |
| Price Hint | 4 |
| Price To Book | 4.354839 |
| Price To Sales Trailing12 Months | 3.137121 |
| Profit Margins | -0.62474996 |
| Quick Ratio | 3.511 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.18999982 |
| Regular Market Change Percent | -7.2519016 |
| Regular Market Day High | 2.64 |
| Regular Market Day Low | 2.39 |
| Regular Market Day Range | 2.39 - 2.64 |
| Regular Market Open | 2.64 |
| Regular Market Previous Close | 2.62 |
| Regular Market Price | 2.43 |
| Regular Market Time | 1,776,793,287 |
| Regular Market Volume | 861,548 |
| Return On Assets | -0.16143 |
| Return On Equity | -0.74877 |
| Revenue Growth | 0.813 |
| Revenue Per Share | 0.808 |
| Sand P52 Week Change | 0.34445214 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 8 |
| Shares Outstanding | 90,869,349 |
| Shares Percent Shares Out | 0.0764 |
| Shares Short | 6,938,356 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 9,161,843 |
| Short Name | Codexis, Inc. |
| Short Percent Of Float | 0.0776 |
| Short Ratio | 1.66 |
| Source Interval | 15 |
| State | CA |
| Symbol | CDXS |
| Target High Price | 11.0 |
| Target Low Price | 2.0 |
| Target Mean Price | 6.58333 |
| Target Median Price | 7.0 |
| Total Cash | 78,209,000 |
| Total Cash Per Share | 0.861 |
| Total Debt | 73,208,000 |
| Total Revenue | 70,387,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.5 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 2.07985 |
| Two Hundred Day Average Change | 0.3501501 |
| Two Hundred Day Average Change Percent | 0.16835354 |
| Type Disp | Equity |
| Volume | 861,548 |
| Website | https://www.codexis.com |
| Zip | 94,063 |